Nabil Andrawis

2.0k total citations
23 papers, 444 citations indexed

About

Nabil Andrawis is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Nabil Andrawis has authored 23 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Nabil Andrawis's work include Nitric Oxide and Endothelin Effects (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Receptor Mechanisms and Signaling (3 papers). Nabil Andrawis is often cited by papers focused on Nitric Oxide and Endothelin Effects (8 papers), Blood Pressure and Hypertension Studies (6 papers) and Receptor Mechanisms and Signaling (3 papers). Nabil Andrawis collaborates with scholars based in United States, Switzerland and Poland. Nabil Andrawis's co-authors include Nicholas M. P. King, D R Abernethy, D. R. Abernethy, D. H. Jones, Irving W. Wainer, James Longstreth, Harry G. Preuss, S. Taylor Jarrell, F Giacomelli and Tuan H. Kuo and has published in prestigious journals such as Nature Medicine, Biochemical and Biophysical Research Communications and Hypertension.

In The Last Decade

Nabil Andrawis

21 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nabil Andrawis United States 13 194 153 112 95 37 23 444
Hiroto Matsuda Japan 14 257 1.3× 134 0.9× 162 1.4× 101 1.1× 40 1.1× 35 589
Sohachi Fujimoto Japan 13 163 0.8× 181 1.2× 163 1.5× 100 1.1× 96 2.6× 18 747
Wieslawa Maniara Switzerland 9 235 1.2× 142 0.9× 58 0.5× 176 1.9× 30 0.8× 15 532
Paul Modlinger United States 8 211 1.1× 135 0.9× 251 2.2× 86 0.9× 69 1.9× 9 653
Ursula Schmid Germany 12 76 0.4× 173 1.1× 104 0.9× 97 1.0× 55 1.5× 15 532
Marlina Manhiani United States 11 146 0.8× 120 0.8× 107 1.0× 283 3.0× 53 1.4× 12 657
Hong-Jye Hong Taiwan 12 191 1.0× 269 1.8× 198 1.8× 48 0.5× 45 1.2× 20 614
Pierre Schiavi France 14 311 1.6× 125 0.8× 90 0.8× 119 1.3× 50 1.4× 23 557
Giorgia Pierelli Italy 6 145 0.7× 156 1.0× 77 0.7× 71 0.7× 50 1.4× 7 494
Maribel Chávez Venezuela 11 236 1.2× 95 0.6× 119 1.1× 238 2.5× 65 1.8× 13 783

Countries citing papers authored by Nabil Andrawis

Since Specialization
Citations

This map shows the geographic impact of Nabil Andrawis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nabil Andrawis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nabil Andrawis more than expected).

Fields of papers citing papers by Nabil Andrawis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nabil Andrawis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nabil Andrawis. The network helps show where Nabil Andrawis may publish in the future.

Co-authorship network of co-authors of Nabil Andrawis

This figure shows the co-authorship network connecting the top 25 collaborators of Nabil Andrawis. A scholar is included among the top collaborators of Nabil Andrawis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nabil Andrawis. Nabil Andrawis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flack, John M., Markus P. Schlaich, Michael A. Weber, et al.. (2025). Aprocitentan for Blood Pressure Reduction in Black Patients. Hypertension. 82(4). 601–610. 2 indexed citations
2.
Bhatt, Deepak L., Harold Bays, Michael Miller, et al.. (2023). The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial. Nature Medicine. 29(7). 1782–1792. 66 indexed citations
3.
Ammann, Eric M., Dejan Milentijevic, Darren A. Talbot, et al.. (2023). Characteristics, management, and blood pressure control in patients with apparent resistant hypertension in the US. Heliyon. 9(2). e13258–e13258. 2 indexed citations
4.
5.
6.
Jones, D. H., Nabil Andrawis, & D. R. Abernethy. (1999). Impaired endothelial-dependent forearm vascular relaxation in black Americans. Clinical Pharmacology & Therapeutics. 65(4). 408–412. 49 indexed citations
7.
Liu, Xiaoke, Nicholas M. P. King, & Nabil Andrawis. (1998). Nitric oxide inhibits Oct-1 DNA binding activity in cultured vascular smooth muscle cells. Life Sciences. 62(8). 739–749. 16 indexed citations
8.
9.
10.
King, Nicholas M. P., Nikia A. Laurie, & Nabil Andrawis. (1995). Local angiotensin-converting enzyme inhibition blunts endothelin-1—induced increase in forearm vascular resistance*. Clinical Pharmacology & Therapeutics. 58(3). 328–334. 10 indexed citations
11.
DePetrillo, Paolo B., et al.. (1994). Verapamil decreases lymphocyte protein kinase C activity in humans. Clinical Pharmacology & Therapeutics. 55(1). 44–49. 9 indexed citations
12.
Abernethy, D R, Irving W. Wainer, James Longstreth, & Nabil Andrawis. (1993). Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.. Journal of Pharmacology and Experimental Therapeutics. 266(2). 904–911. 43 indexed citations
13.
Andrawis, Nabil & Nicholas M. P. King. (1993). Effect of Calcium Antagonists on RNA Synthesis of NIH 3T3 Cells. The American Journal of the Medical Sciences. 306(3). 137–140. 4 indexed citations
14.
Abernethy, D R & Nabil Andrawis. (1993). Critical drug interactions: A guide to important examples. 19(10).
15.
Andrawis, Nabil, V J Dzau, & Richard E. Pratt. (1992). Autocrine stimulation of mas oncogene leads to altered. Cell Biology International Reports. 16(6). 547–556. 8 indexed citations
16.
Andrawis, Nabil, et al.. (1992). Endothelin-I—mediated vasoconstriction: Specific blockade by verapamil. Clinical Pharmacology & Therapeutics. 52(6). 583–589. 14 indexed citations
17.
Andrawis, Nabil & D R Abernethy. (1992). Verapamil blocks basal and angiotensin II-induced RNA synthesis of rat aortic vascular smooth muscle cells. Biochemical and Biophysical Research Communications. 183(2). 767–773. 12 indexed citations
18.
Andrawis, Nabil, et al.. (1992). Calcium antagonists block angiotensin II-mediated vasoconstriction in humans: comparison with their effect on phenylephrine-induced vasoconstriction.. Journal of Pharmacology and Experimental Therapeutics. 261(3). 879–884. 17 indexed citations
19.
Andrawis, Nabil, Tommy A. Brock, V J Dzau, & Richard E. Pratt. (1991). Mas Oncogene Receptor Coupling and Peptide Specificity in Balb 3T3 and Vascular Smooth Muscle Cells. The American Journal of the Medical Sciences. 302(6). 329–334. 2 indexed citations
20.
Andrawis, Nabil, Tuan H. Kuo, F Giacomelli, & Jeffrey Wiener. (1988). Altered calcium regulation in the cardiac plasma membrane in experimental renal hypertension. Journal of Molecular and Cellular Cardiology. 20(7). 625–634. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroto Matsuda Breakdown of academic impact, for papers by Sohachi Fujimoto Breakdown of academic impact, for papers by Wieslawa Maniara Breakdown of academic impact, for papers by Paul Modlinger Breakdown of academic impact, for papers by Ursula Schmid Breakdown of academic impact, for papers by Marlina Manhiani Breakdown of academic impact, for papers by Hong-Jye Hong Breakdown of academic impact, for papers by Pierre Schiavi Breakdown of academic impact, for papers by Giorgia Pierelli Breakdown of academic impact, for papers by Maribel Chávez
Rankless by CCL
2026